Food News and Research

RSS

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).

30 Dec 2015

AlloSource receives two patents for cartilage repair allografts

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, received two patents from the United States Patent and Trademark Office for cartilage repair allografts.

29 Dec 2015

Mylan announces launch of Linezolid Tablets, 600 mg in U.S.

Mylan N.V. today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer's Zyvox Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.

29 Dec 2015

E-cigarettes damage cells in ways that could lead to cancer

Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.

29 Dec 2015

FDA approves non-alcoholic Docetaxel Injection

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

29 Dec 2015

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.

28 Dec 2015

Norway’s tradition of brewing Christmas beer

The brewing of Christmas beer in Norway is a very old tradition and dates back to pre-Christian times, at least.

28 Dec 2015

Julphar's DEXCOM G4 PLATINUM CGM system now available in GCC

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.

28 Dec 2015

New study looks at overconsumption of 'healthy' foods

Eating too much is typically considered one of the prime culprits of obesity. A new study published in the Journal of the Association for Consumer Research, looked specifically at overconsumption of "healthy" foods which consumers often perceive as less filling.

28 Dec 2015

Healthier weight using genetic data for customized diets and physical activity plans

Some health experts predict that the next big advance in helping overweight people achieve a healthier weight will be to use an individual's genetic data to customize diets and physical activity plans, an approach known as "precision weight loss.

24 Dec 2015

Selexipag holds promise for treatment of pulmonary hypertension

Living with pulmonary arterial hypertension is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data to be published in the Dec. 24 issue of the New England Journal of Medicine.

24 Dec 2015

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.

24 Dec 2015

Eating at the wrong time of day affects learning and memory

An occasional late-night raid on turkey leftovers might be harmless but new research with mice suggests that making a habit of it could alter brain physiology.

24 Dec 2015

Working Group identifies many potential genetic contributors to weight loss

In the midst of the holiday season, celebratory get-togethers can mean overindulging on treats and high-calorie foods, leaving many of us struggling to keep off the extra pounds. With as many as two-thirds of American adults already carrying excess weight, and one third with obesity, maintaining weight can be the biggest challenge, say researchers.

24 Dec 2015

EMA CHMP considers AcelRx's ARX-04 for acute pain treatment for centralized review

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.

24 Dec 2015

Chapters Capistrano warns holiday memories can increase alcohol consumption

For many, the holidays mean celebrating with friends and family, exchanging gifts, and indulging in delicious food. But they can also elicit memories that some would rather forget and may lead them to drink in an effort to cope.

23 Dec 2015

Study shows pathogens can survive in dry foods for long periods of time

Researchers at the University of Georgia found that pathogens, like salmonella, can survive for at least six months in cookies and crackers.

23 Dec 2015

Financial burden affects cancer patients without paid sick leave

Cancer can cause an enormous financial burden for some patients. Now a new study finds the burden is worse for patients without paid sick leave.

23 Dec 2015

Migration of resistant strains poses risk for food safety, may increase human intoxication

A seaweed from Asia - used for human nutrition - contains toxic compounds providing protection against animal consumers.

23 Dec 2015

Researchers identify transporters responsible for arsenic accumulation in plant seeds

Researchers from FIU's Herbert Wertheim College of Medicine Barry P. Rosen and Jian Chen, both from the Department of Cellular Biology and Pharmacology, are part of an international team that has identified how arsenic gets into the seeds of plants such as rice. T

23 Dec 2015